Consensus Bruker Corporation

Stocks

BRKR

US1167941087

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 16:00:00 2026-10-23 EDT			5-day change	1st Jan Change
57.59 ^USD	+0.49%		+5.09%	+22.25%

10-14	JPMorgan Downgrades Bruker to Neutral From Overweight, Price Target is $60	MT
09-28	Bruker Corporation Announces New Timsultra Aip and Timsomni Workflows for Drug Discovery and Development and Disease Biology Research	CI

Evolution of the Average Target: Bruker Corporation

Evolution of the Target Price: Bruker Corporation

Changes in Analyst Recommendations: Bruker Corporation

0142fe4ca733c90731b223f72.eF1q2p-J-nL_3IYeCeIrv2Vych_wFRZO81bQw-rn0T4.OhQiuaq-g0G7uNEqXIxb3jEoHlyDc1B6ixC0oIWI4FMBPyug9KSAFc6Zxw~aa45679c9a84c6293edabab2c48f01fd

Analysts' recommendations: Bruker Corporation

10-14	JPMorgan Downgrades Bruker to Neutral From Overweight, Price Target is $60	MT
09-21	Analyst recommendations: Flutter, Constellation Brands, CoreWeave, eBay, Meta Platforms…
09-09	UBS Adjusts Bruker Price Target to $65 From $45, Maintains Neutral Rating	MT
07-13	BofA Securities Adjusts Bruker Price Target to $70 From $65	MT
06-02	BofA Securities Adjusts Bruker Price Target to $65 From $49	MT
06-01	Analyst recommendations: Caesars Entertainment, Dell Technologies, AMD, Dycom Industries…
05-07	UBS Adjusts Price Target on Bruker to $45 From $40, Maintains Neutral Rating	MT
02-13	UBS Adjusts Price Target on Bruker to $40 From $43, Maintains Neutral Rating	MT
12-10	Wolfe Research Upgrades Bruker to Outperform From Peer Perform, $60 Price Target	MT
11-20	Rothschild & Co Redburn Initiates Coverage on Bruker With Buy Rating, $60 Price Target	MT
11-04	UBS Adjusts Price Target on Bruker to $43 From $40, Maintains Neutral Rating	MT
11-04	Analysts recommendations: Apple, Comcast, Crocs, Eli Lilly, Palantir…
11-03	(BRKR) Bruker Expects 2025 Non-GAAP EPS Range $1.85 to $1.90, vs. FactSet Est of $1.93	MT
11-02	Certain Restricted Stock Units of Bruker Corporation are subject to a Lock-Up Agreement Ending on 3-NOV-2025.	CI
25-05-22	Citigroup Downgrades Bruker to Neutral From Buy, Lowers Price Target to $40 From $50	MT
25-05-08	UBS Cuts Price Target on Bruker to $45 From $57, Keeps Neutral Rating	MT
25-04-14	BofA Securities Lowers Bruker Price Target to $61 From $76	MT
25-02-14	The glass is always half full
25-02-14	Analyst recommendations: Bunzl, Bellway, Shell, Coinbase, Spotify…
25-02-14	Analyst recommendations: Airbnb, Datadog, Avis, Coinbase, Roku...
24-12-19	Guggenheim Initiates Coverage on Bruker With Buy Rating, $72 Price Target	MT
24-12-10	UBS Downgrades Bruker to Neutral From Buy, Cuts Price Target to $66 From $102	MT
24-12-05	Goldman Sachs Upgrades Bruker to Neutral From Sell, Price Target is $60	MT
24-09-30	Wolfe Research Downgrades Bruker to Peer Perform From Outperform	MT
24-07-09	Goldman Sachs Adjusts Price Target on Bruker to $60 From $72, Maintains Sell Rating	MT

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	BRUKER CORPORATION					+10.84%
	THERMO FISHER SCIENTIFIC, INC.					+11.44%
	DANAHER CORPORATION					+12.45%
	INTUITIVE SURGICAL, INC.					+5.75%
	BOSTON SCIENTIFIC CORPORATION					+26.55%
	VEEVA SYSTEMS INC.					-6.96%
	SIEMENS HEALTHINEERS AG					+8.44%
	EDWARDS LIFESCIENCES CORPORATION					+13.83%
	AGILENT TECHNOLOGIES, INC.					+4.95%
	WATERS CORPORATION					+2.69%
	Average					+9.00%
	Weighted average by Cap.					+9.83%